Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are more common in people with diabetes.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Not all drugs have an easy path to market ... would be the only adjunct therapy to insulin for patients with type 2 diabetes and chronic kidney disease if approved. The patient need is also ...